Standard Contracts
3,400,000 Shares Myriad Genetics, Inc. COMMON STOCK, $0.01 par value UNDERWRITING AGREEMENTUnderwriting Agreement • June 4th, 2004 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • New York
Myriad Genetics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Morgan Stanley & Co. Incorporated (the “Underwriter”) 3,400,000 shares of its common stock, $0.01 par value per share (the “Firm Shares”). The Company also proposes to issue and sell to the Underwriter not more than an additional 510,000 shares of its common stock, $0.01 par value per share (the “Additional Shares”), if and to the extent that you shall have determined to exercise the right to purchase such shares of common stock granted to you in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, $0.01 par value per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
